Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Apr 29;15(4):e248668.
doi: 10.1136/bcr-2021-248668.

Chronic inflammation and calciphylaxis

Affiliations
Case Reports

Chronic inflammation and calciphylaxis

Aaron Byers et al. BMJ Case Rep. .

Abstract

Calciphylaxis also known as calcific uraemic arteriolopathy is a rare condition mostly seen in patients with end-stage kidney disease. We report a case of a simultaneous-kidney-pancreas transplant patient with functioning grafts developing biopsy-proven calciphylaxis in the setting of chronic inflammation. Despite several modalities of management, the patient developed progression of her disease leading to multiple amputations. This case illustrates chronic inflammation driven by persistent infection as a probable contributing factor to the development and progression of calciphylaxis in a simultaneous kidney-pancreas recipient. Calciphylaxis should be considered in the differential for a painful, non-healing ulcer even in the absence of common risk factors.

Keywords: Immunology; Renal transplantation.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Picture showing bilateral macular rash on the dorsum of both feet.
Figure 2
Figure 2
Ulcer with overlying eschar at the time of hospital admission 1-year post-transplant.

References

    1. Bajaj R, Courbebaisse M, Kroshinsky D, et al. . Calciphylaxis in patients with normal renal function: a case series and systematic review. Mayo Clin Proc 2018;93:1202–12. 10.1016/j.mayocp.2018.06.001 - DOI - PubMed
    1. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med 2018;378:1704–14. 10.1056/NEJMra1505292 - DOI - PubMed
    1. Weenig RH, Sewell LD, Davis MDP, et al. . Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 2007;56:569–79. 10.1016/j.jaad.2006.08.065 - DOI - PubMed
    1. Korkmaz C, Dündar E, Zubaroğlu I. Calciphylaxis in a patient with rheumatoid arthritis without renal failure and hyperparathyroidism: the possible role of long-term steroid use and protein S deficiency. Clin Rheumatol 2002;21:66–9. 10.1007/s100670200016 - DOI - PubMed
    1. Dutta P, Chaudet KM, Nazarian RM, et al. . Correlation between clinical and pathological features of cutaneous calciphylaxis. PLoS One 2019;14:e0218155. 10.1371/journal.pone.0218155 - DOI - PMC - PubMed

Publication types